{"university":{"openalex_id":"I4388446366","name":"Indiana University Indianapolis"},"topic":"age-crosslink-breakers","total_matching":2,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1002/jbmr.3925","title":"Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD","source_url":"https://doi.org/10.1002/jbmr.3925","source_name":"Journal of Bone and Mineral Research","cited_by_count":46,"is_open_access":true,"openalex_work_id":"W2990425860","publication_date":"2019-11-19","publication_year":2019,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1161/jaha.122.028081","title":"Treatment With Small Molecule Inhibitors of Advanced Glycation End‐Products Formation and Advanced Glycation End‐Products‐Mediated Collagen Cross‐Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice","source_url":"https://doi.org/10.1161/jaha.122.028081","source_name":"Journal of the American Heart Association","cited_by_count":18,"is_open_access":true,"openalex_work_id":"W4375956189","publication_date":"2023-05-09","publication_year":2023,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}